Sign in

CIK 0002028614 · <br>Emerging growth company

Drugs Made In America Acquisition Corp.

Sign in to watch
Ticker
DMAA
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
646-726-7074
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMAA Ordinary Shares Nasdaq
  • DMAAR Rights Nasdaq
  • DMAAU Units Nasdaq
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 8-K Event Material agreement · Other events
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Material agreement
  5. 10-Q Report Quarterly Report
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 8-K Event Material agreement
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 10-Q Report Quarterly Report
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 8-K Event Material agreement
  17. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
  18. 8-K Event Material agreement
  19. DEFR14A Other DEFR14A
  20. 10-K Report Annual Report

Page 1 of 4 · 80 filings